Purpose. Neisseria meningitidis is the leading global cause of meningitis and sepsis. Detection, followed by identification, of bacterial pathogens is important in medicine and public health. In the present study, we used the ribosome display technique to select single-chain variable fragments (scFv) that are specific to the surface-exposed fHbp antigen of N. meningitidis.
INTRODUCTION
Meningitis has many potential causes, either infectious or non-infectious. Neisseria meningitidis is the primary cause of meningococcal meningitis, which only affects humans [1] . This meningococcal meningitis can be fatal if the disease is not treated quickly and efficiently. Although there are 12 known serogroups of N. meningitidis based on different capsular polysaccharide structures, five of these serogroups, namely, A, B, C, W and Y, are the most important [2] . In addition to the traditional serology-based method, conventional polymerase chain reaction (PCR) and real-time PCR have been used to detect meningococcal DNA [3] . Serogroup B is difficult to detect and only develops an immune response to specific vaccination [4] . N. meningitidis has different surface antigens. One of these, the factor H-binding protein (fHbp), was initially identified as a lipoprotein that is present on the neisserial surface with an unknown function, and was recently renamed genomederived Neisseria antigen 1870 (GNA1870) [5] , while it is also known as lipoprotein 2086 [6] .
Some bacterial and viral pathogens avoid the complement system by recruiting factor H (fH) to their surfaces [7] . A previous study had shown that the interaction between fH and fHbp is the basis of the fH-binding meningococcal protein [8] . Although fH-binding proteins have been identified in many pathogens, the sequence and structure of these proteins in N. meningitidis and a few other Neisseria species are unique [9] . Sequencing of the fHbp gene across different strains has shown that it has been divided into three main variants (var1, var2 and var3) [10] . Conservation within each variant ranges from 91.6 to 100 %, whereas that between the variants can be as low as 62.8 % [5] .
Rapid, accurate, and precise detection of pathogens is very important in the treatment of infectious diseases. This aspect has given rise to most targeted studies in recent times, such as those involving the use of monoclonal antibody technology [11] .
In the last few years, antibody fragments have shown high potential for the detection of infectious agents. These are small proteins based on single-domain antibody fragments that carry the full antigen-binding capacity of natural antibodies. The single-chain variable fragment antibody (scFv) is composed of the V regions of an antibody's heavy (VH) and light(VL) chains joined with a short flexible peptide linker that has a unique ability to bind many antigens, such as proteins and even whole pathogens. There are six hypervariable domains called complementarity-determining regions (CDRs) in both VH and VL chains [12] . Therefore, scFv might be an ideal candidate for use in diagnostics because it can be easily applied in routine techniques such as the enzyme-linked immunosorbent assay (ELISA) [13, 14] .
Display systems are used for the selection of coding elements (DNA or RNA) from libraries. Cell-based methods such as phage display and in vitro display techniques, including ribosome display, have facilitated fundamental improvements in the field of antibody engineering, especially with respect to the scFv antibody [15] . The library is at times a ligand for specific proteins. The expression of this library in prokaryotic or eukaryotic cells (phage display or yeast display) might be toxic for the cell; however, this issue can be resolved by using the transcription and translation machinery extracted from prokaryotic or eukaryotic cells. Ribosome display, a completely cell-free display method described by Mattheakis et al. [16] , allows easy screening to isolate specific binders to objective ligands [17, 18] . This technique can help generate large libraries without involving a transformation step; the libraries can be diversified by PCR, and toxic reagents can be selected [19] . In this method, nascent single-chain antibodies (phenotype) link to their encoding mRNA (genotype) to form antibodyribosome-mRNA (ARM) complexes. During selection, the ternary complexes bind to their specific target antigens, and nonspecific complexes are removed by stringent washing. Targeted mRNAs are extracted from the remaining compounds and reverse-transcribed to cDNA and amplified by PCR [20] .
In this study, we constructed an scFv antibody library and used the ribosome display technique to directly pan scFvs for fHbp variant 1 [10] , with the aim of selecting a specific novel scFv that binds to this antigen with high affinity.
METHODS
Immunization of mice with the recombinant fHbp protein Three female BALB/c mice (age, 4 weeks) were purchased from the Pasteur Institute (Tehran, Iran) and administered with an intraperitoneal injection of a 1 : 1 (v/v) mixture of 30, 50 and 70 (µg ml À1 ) fHbp protein that was conjugated with the His-tag peptide [21] and Freund's complete adjuvant (Sigma, USA). Then, 10 and 14 days after the first injection, booster injections were administered, with the same amount of antigen and Freund's incomplete adjuvant, respectively. As a control, one mouse was injected with phosphate-buffered saline (PBS) mixed with the adjuvant. Before the mice were sacrificed, their sera were analysed by ELISA. An immunized mouse with the highest serum antibody titre against fHbp was sacrificed by cervical dislocation, and the spleen cells were targeted for RNA extraction.
Construction of the scFv chain library Total RNA was extracted from the spleen cells by using a Total RNA Purification kit (Jena Bioscience, Germany), according to the manufacturer's instructions. Complementary DNAs (cDNAs) were amplified by RT-PCR using the Oligo (dT) primer. VH/back and VH/for primers were used to amplify the DNA that encoded VH (94 C for 40 s, 54 C for 1 min and 72 C for 1 min; 30 cycles). The DNA-encoding k-chain was also amplified with Ck/back and VL/for primers by PCR, using the same programme described for the amplification of VH fragments (Table 1) [22] . A 72-bp-long DNA sequence (5¢GTCACCGTCTCCTCAGGTGGTGG TGGTAGCGGCGGCGGCGGCTCTGGTGGTGGTGGAT CCGACATTGAGCTCACCC3¢), including a flexible DNA linker (Gly4Ser)3, synthesized by Bioneer (Republic of Korea), was used to connect the VH fragments to the kchains by splicing by overlap extension (SOE) PCR [23] .
Once the VH fragments were amplified by PCR using the above-mentioned specific primers, the linker fragment was amplified with specific primers (Table 1) . Gel purification of the VH and linker fragments was carried out using a Gel Purification kit (Bioneer). Next, 15 ng of the VH DNA and 20 ng of the linker DNA were mixed with 25 µl of the PCR mixture without primers and subjected to 25 cycles of amplification (1 cycle: 1 min at 94 C, 2 min at 60 C and 2 min at 72 C) to join the linker DNA to the VH DNA. The assembled DNA was amplified in a 50 µl PCR mixture for 25 cycles (1 cycle: 1 min at 94 , 1 min at 54 C and 1 min at 72 C) using T7/bac and link/R primers. The recombinant DNA that encoded the single-chain antibody library in the VH/k format was constructed by linking the VH-linker fragments and k-chains. Therefore, 15 ng of VH-linker DNA and 50 ng of k-chain DNA were mixed with 25 µl of the PCR mixture without primers, and PCR was performed according to the programme used to join VH and the linker. The assembled DNA was amplified in a 50 µl PCR mixture for 25 cycles (as mentioned above) using the T7/back and Ck/for primers [18, 24] . The T7/bac primer included a ribosome-binding site and a T7 promoter (underlined), and the Ck/for primer contained a nonstop codon. The VH/k PCR library was stored at À20
C.
In vitro transcription and translation of the antibody-coding gene library (ribosome display) The 0.5 ml PCR tubes were coated with 100 µl of recombinant fHbp antigen (10 µg ml À1 in PBS) at room temperature for 16 h. They were washed with cold PBS and blocked with 100 µl of molecular biology-grade bovine serum albumin (BSA)-PBS (10 mg ml À1 ) (New England BioLabs, UK) for 1 h. In vitro transcription and translation of the antibodycoding genes were performed using TNT T7 Quick Master Mix (Promega, USA). The reaction volume was 25 µl and contained 20 µl of the TNT T7 Quick Master Mix, 1 µl of the DNA library (0.1-1 µg), 0.5 µl of methionine and 3.5 µl of nuclease-free water. After incubation at 30 C for 90 min, 6 µl of RNase-free DNase I (Fermentase, Lithuania) was added, and the mixtures were incubated at 30 C for 30 min [25] . To select the specific antibody fragments, the mixtures, which included the ARM complexes, were added to the prepared PCR tube (antigen-coated), and incubated on ice for 1 h. After three washes with PBS (containing 10 mg ml À1 BSA and 5 mM MgCl 2 ), the retained ribosomal complexes were dissociated by adding 200 µl of PBS and 20 mM EDTA for 10 min on ice [22] . The mRNAs in dissociating buffer were isolated using an RNA Purification kit (Jena Bioscience, Germany) and recovered by RT-PCR using the primers VH/back-NcoI and Vk/for-NotI (Table 1) containing NcoI and NotI restriction sites (underlined), and then cloned into the expression vector. The obtained PCR products were cloned into the pTG19-T vector (SinaClon, IRAN) and sequenced using the Sanger sequencing method [26] (Bioneer, Republic of Korea).
Cloning, expression and purification of selected scFv cDNAs The DNA fragments generated using the above-described steps were digested with NotI and NcoI and ligated into the pET28a (+) vector (Novagen, USA) for expression of the antibody fragments. Single colonies of Escherichia coli BL21 (DE3) containing the expression plasmids were grown in Luria-Bertani medium containing 30 µg ml À1 kanamycin at 37 C, until a density corresponding to an optical density (OD 600 ) of 0.6 was reached. Then, 0.5 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) was added to induce the expression of the recombinant protein. The scFv proteins with the His-tag were subjected to SDS-PAGE using a 10 % polyacrylamide gel. The samples were mixed with 2Â loading buffer (125 mM Tris, 20 % glycerol, 4 % SDS and 0.01 % bromophenol blue at pH 6.8). The gels were stained with Coomassie brilliant blue R-250. For antibody analysis by Western blotting, the recombinant proteins were separated on a 10 % polyacrylamide gel and electrophoretically transferred to a nitrocellulose membrane (Whatman, UK). The membrane was incubated with 1 : 2000-diluted alkaline phosphatase (ALP)-labelled anti-His tag monoclonal antibody (Abcam, UK). NBT/BCIP substrate solution (Roche, Germany) was used as an ALP substrate to visualize the immunoreactivity.
The recombinant His-tagged scFvs were purified by affinity chromatography using Ni 2+ -NTA agarose resin (Novagen, USA). The pellet was resuspended in 5 ml of denaturing buffer (6 M Urea, 20 mM NaH 2 PO 4 and 500 mM NaCl, pH 8.0) and lysed by sonication on ice. After chromatography was performed, the bound antibodies were eluted with 1 ml of elution buffer (500 mM imidazole, 20 mM NaH 2 PO 4 and 500 mM NaCl, pH 8.0) [27] and dialyzed in PBS at room temperature for 2 h.
ELISA-based evaluation of the binding activity of the selected scFv clones The recombinant fHbp that was conjugated to the S-Tag peptide (2 µg ml À1 in PBS), E. coli lysate (BL21) and BSA (2 µg ml À1 in PBS) was coated on a microtitre plate and incubated overnight at room temperature. After blocking Primers for the construction of the scFv DNA library for ribosome display
Primers for the cloning of scFvs
Vk/for-NotI 5¢ATATATATATGCGGCCGC ‡TGCAGCATCAGCCCGTTT3¢
*T7 promoter and TATA box. †NcoI restriction site. ‡NotI restriction site.
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with PBSB (PBS containing 3 % (w/v) BSA), 100 µl of the extracted scFv antibody diluted with PBS with Tween 20 (PBST) (5 µg ml À1 ) was added to the antigen-coated well and incubated for 5 h at 37 C. Horseradish peroxidase (HRP)-conjugated anti-His tag antibody (Abcam, UK) (diluted 1/10 000 in PBST) was used as the secondary antibody. The immunoreaction was developed by adding 50 µl of 3,3¢,5,5¢-tetramethylbenzidine (TMB), and then stopped after 20 min by adding 50 µl of 2 N H 2 SO 4 . The absorbance was measured at 450 nm.
Determination of affinity and specificity of the selected scFvs The precise nature of the selected scFvs was determined using Bact-ELISA. N. meningitidis (ATCC 13090), N. sicca, Streptococcus pneumonia and E. coli (obtained from the Laboratory of Medical Microbiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran), fHbp (as the positive control) and BSA (as the negative control) were used. Each bacterium was inactivated at 56 C for 1 h; then, 100 µl of the bacterial suspension in PBS [10 7 colony-forming units (c.f.u.)] was inoculated into individual wells and allowed to dry overnight at 37 C [28] .
The affinity of the isolated scFv against the recombinant fHbp was assessed using the method described by Beatty et al. [29] . In brief, the ELISA wells were coated with the recombinant S-tagged fHbp protein at a concentration of 2, 1, 0.5 and 0.25 µg ml À1 in carbonate/bicarbonate buffer at a pH of 7.2 at 4 C overnight. For each concentration of the coated recombinant fHbp, 5, 2.5, 1.25 and 0.625 µg ml À1 scFv antibody was used separately. ELISA was performed, and the mathematical formula detailed below was used to calculate the K aff [29] of the isolated scFv to the recombinant fHbp protein. [29] .
Prediction of the frameworks and hypervariable regions (CDRs) of the scFv 6 antibody domains IMGT/V-QUEST is sequence alignment software for the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences of the variable regions and domains. It was developed by LIGM (Universit e Montpellier 2, CNRS) and has been available on the internet since 7 July 1997 [30, 31] . The complementary determining regions (CDRs) of the scFv clone 6 were determined using the IMGT/V-QUEST database [32] .
RESULTS

Mouse immunization and serum ELISA
The blood of each immunized mouse was collected, and their immune response was determined by ELISA (Fig. 1) .
Construction of a VH/k chain library
For library construction, the k-chain containing the VL and a part of the constant region of k-chain and the VH fragments were amplified by PCR using specific primers ( Table 1 ). The final DNA fragments (~1100 bp) (Fig. 2 , arrow pointing to the right), including the library of the mouse antibody genes, were used for in vitro ribosome display.
Library expression and isolation of scFvs by using the eukaryotic ribosome display system After the ribosome display steps, a 720-bp band (Fig. 2 , arrow pointing downward) amplified by using scFv-specific primers was cloned into the pTG19-T vector. Approximately 50 white colonies were obtained, all of which were investigated by PCR using the M13 primer (data not shown). Colonies showing the 720-bp bands (Fig. 2) were sequenced (12 colonies). Of these, six colonies with the correct reading frame were selected for expression.
Cloning, expression, and purification of scFvs All six scFvs cloned into the pET28a (+) vector were expressed and purified by affinity chromatography using the Ni 2+ -NTA agarose resin. Fig. 3 illustrates the results of Fig. 1 . ELISA analysis of mouse immune serum evaluation. Mice A to C (injected with fHbp protein) and control (injected with PBS) sera from bleed (1 : 3000 dilution) in the ELISA performed with purified fHbp protein (2 µg ml À1 ) and BSA (2 µg ml À1 ).
SDS-PAGE and Western blotting of the purified and selected scFvs (27 kD).
Functional assay of the purified scFvs by ELISA We used ELISA to determine the functions of purified scFvs. The results indicate that among all six purified scFvs, clone 4 and 6 exhibited enhanced binding activity to fHbp (Fig. 4a) . The affinity constants of these clones were 7.03Â10 9 M À1 and 8.65Â10 9 M
À1
, respectively (Fig. 4b) . We selected clone 6, according to the affinity measurement results, for specificity analysis. The specificity of the targeted clone was analysed by performing Bact-ELISA with N. meningitidis B (ATCC 13090), N. sicca, S. pneumoniae E. coli, fHbp (as the positive control) and BSA (as the negative control) (Fig. 5) . A cross-reaction assay with all of the bacteria and BSA showed negligible reactions, while recombinant fHbp and N. meningitidis B (ATCC 13090) showed considerable immunoreaction with scFv clone 6.
Sequence analysis of the selected scFv
The VH and VL sequences of the scfv clone 6 antibody were aligned into the IMGT/V QUEST website and the complementarity-determining regions (CDRs) and frameworks were determined separately (Fig. 6 ).
DISCUSSION
The primary purpose of this study was to select an scFv antibody that was specific to the fHbp antigen of N. meningitidis by ribosome display. In >99 % of the known clinical serogroups of N. meningitidis, fHbp has been suggested to be a crucial protein [1] , and so we scrutinized this novel protein to select scFv antibodies with high binding potential.
In addition to several technologies for designing monoclonal antibodies, such as hybridoma technology [33] , some recombinant antibody display technologies such as ribosome display and phage display systems [34] are useful options to limit laboratory work and construct antibody libraries efficiently [35] . The scFv is an engineered antibody that is associated with the VH and VL chains of immunoglobulins with a short polypeptide linker. It has also been used to generate ligands to detect pathogenic bacteria in vitro or in vivo [36, 37] . Manipulation of the scFv antibody to improve its specificity and affinity might be an easier option than using the methods that produce polyclonal antibodies via the hybridoma technology [38, 39] . Practically, we were able to identify the binding properties of scFvs and assay their potential as diagnostic tools or therapeutic agents by involving the panning method [40] .
Different sources of antibody pools (namely, immune, naïve and synthetic) were used for library preparation [41] . In cell-based display methods, the restriction on the library size is the primary limitation, and so in this study we used a cell-free display system in which libraries were constructed from the immune type of antibody pool.
In our previous study, we prepared a recombinant fHbp [21] and used it to immunize BALB/c mice. According to the protocol described by He and Taussig [18] , the DNA library of VH/k antibody fragments was constructed using the SOE-PCR method. Using this cDNA library, we were able to show fHbp-specific selection and enrichment via ribosome display technology. Ribosome display is a fully cell-free display method. To use this method, the transcription and translation processes were performed in two ways: (1) the E. coli system and (2) the rabbit reticulocyte system [35, 42] . Because the rabbit reticulocyte system had lower RNase activity compared to the E. coli system, and because eukaryotic conditions might recover the translation and folding output of some proteins [43, 44] , we used the eukaryotic ribosome display system to select a specific antibody against meningitis.
Most studies have used the whole cell for immunization and library generation [25, 45] by repeating the panning step more than once [45, 46] . Here, we used the recombinant fHbp (a pathogen-specific protein) and undertook only one panning step. Finally, after investigating a limited number of clones (six), we found two clones with acceptable affinities. One possible explanation of our results is that the use of specific proteins for immunization and library production has a direct effect on the isolation of specific antibodies. By examining the obtained clones, we observed that some clones had a high binding affinity to BSA, which might be due to insufficient washing at the panning stage. In some studies that used ribosome display to select a specific scFv, the affinity of the isolated scFvs was calculated to be up to 10 10 M À1 [45, 46] . In our study, the affinity was determined to be a reasonable value of 10 9 M À1 by using the Beatty method [29] . Fig . 5 . Specificity analysis for scFv using Bact-ELISA. The purified protein of scFv clone 6, as the primary antibody (5 µg ml À1 ), was tested against some inactivated bacteria by Bact-ELISA. N. meningitidis (ATCC 13090), St. pneumonia, N. sicca, E. coli, BSA (2 µg ml
À1
) and purified fHbp protein (2 µg ml À1 ) were coated.
These results indicate that the anti-fHbp clone 6 scFv has high affinity to the recombinant fHbp and is acceptably specific to the N. meningitidis B strain.
In this study, because of the limited availability of N. meningitidis strains, other bacteria, such as N. sicca, St. pneumonia and E. coli, were obtained from Laboratory of Medical Microbiology, Shahid Beheshti University of Medical Sciences, as a gift. However, more experiments are underway.
Because of the need to identify different N. meningitidis serogroups on the basis of surface polysaccharides and the failure of serogroup B identification, we designed this study to detect meningitis accurately based on the common antigen present across all five important serogroups. It is expected that the selected specific scFv antibody has the potential to increase the efficiency of the detection of N. meningitidis serogroups in the cerebrospinal fluid.
A previous study showed that the structure of the selected scFv and its binding to the fHbp antigen can be characterized by bioinformatics; the findings from that study suggested that these epitopes are important for vaccine design and additional studies [32] .
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